Isolation of human monoclonal antibodies with neutralizing activity to a broad spectrum of SARS-CoV-2 viruses including the Omicron variants

Ueno, M; Iwata-Yoshikawa, N; Matsunaga, A; Okamura, T; Saito, S; Ashida, S; Yoshida, I; Nagashima, M; Asakura, H; Yaoita, Y; Suzuki, J; Sadamasu, K; Yoshimura, K; Kutsuna, S; Shiwa-Sudo, N; Nagata, N; Suzuki, T; Suzuki, A; Okamoto, M; Kimura, M; Ohmagari, N; Miura, R; Ishizaka, Y

Ishizaka, Y (通讯作者)，Natl Ctr Global Hlth & Med, Dept Intractable Dis, Shinjuku Ku, Toyama 1-21-1, Toyama 1628655, Japan.;Miura, R (通讯作者)，EVEC Inc, Sapporo Lab, Atsubetsu Ku, Technopk 1 Chome, Sapporo, Hokkaido 0040015, Japan.

ANTIVIRAL RESEARCH, 2022; 201 ():

Abstract

Monoclonal antibody therapy is a promising option for severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) infection, and a cocktail of antibod......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索